|
|
|
Volumn 15, Issue 2, 2005, Pages 87-
|
|
Editorial comment: Screening and treatment of AIN to prevent anal cancer - Where do we stand?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
ANAL INTRAEPITHELIAL NEOPLASIA;
ANUS CANCER;
ANUS TUMOR;
CANCER GRADING;
CANCER RECURRENCE;
CANCER RISK;
CANCER SCREENING;
CYTODIAGNOSIS;
DIGITAL RECTAL EXAMINATION;
FEMALE;
HIGH RISK POPULATION;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
LYMPHOCYTE COUNT;
MALE;
MORBIDITY;
NONHUMAN;
NOTE;
SCREENING TEST;
TUMOR GROWTH;
UTERINE CERVIX CARCINOMA IN SITU;
VIRUS REACTIVATION;
WART VIRUS;
CARCINOMA IN SITU;
COMPARATIVE STUDY;
ISOLATION AND PURIFICATION;
MASS SCREENING;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PAPILLOMA VIRUS;
PATHOLOGY;
PRECANCER;
PRIMARY PREVENTION;
PROGNOSIS;
RISK ASSESSMENT;
UTERINE CERVIX TUMOR;
VIRUS INFECTION;
ANUS NEOPLASMS;
CARCINOMA IN SITU;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
FEMALE;
HUMANS;
MALE;
MASS SCREENING;
PAPILLOMAVIRIDAE;
PAPILLOMAVIRUS INFECTIONS;
PRECANCEROUS CONDITIONS;
PRIMARY PREVENTION;
PROGNOSIS;
RISK ASSESSMENT;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 23044452070
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (1)
|
